结账时使用优惠码 EARLY,首单立减 20%。 查看套餐
结账时使用优惠码 EARLY,首单立减 20%。 查看套餐
结账时使用优惠码 EARLY,首单立减 20%。 查看套餐
22° CAD anno 2011 SIMPOSIO N.O.T.E.S. No (visible) Scar Surgery Current clinical applications and future perspectives Presidente: R. PUGLIESE (Milano) Moderatore: G. COSTAMAGNA (Roma) A. FORGIONE (Milano) M.M. LIRICI (Roma) Totally transanal endoscopic surgery: the step forward in no scar colorectal surgery P. Sylla (Boston USA)
此视频尚未进行分析
登录后即可运行 AI 分析或转录。
Oh, good morning. Sorry for the delay, but you know Professor Leroy, and so you can understand.
So thank you so much for being here this morning.
And Patricia Silla is in Boston.
She's a professor at Harvard University, and she's really one of the pioneers of the transanal approach for colorectal diseases.
and you will see a completely different approach to deal with with notes because
she's using a rigid platform that seems much more surgical platform and so for
sure we will learn many many things from her so thank you so much and please
start your presentation thank you very much for the opportunity I want to thank
Thank you, and Professor Palazzini, for the invitation.
Transanally, so here we grab the specimen and pull it out
and remove the TEM platform,
and you'll see the length of rectosigmoid that we can dissect is variable
based on how well we could mobilize proximally.
But here this is an example of how much colon you can get.
But what impressed us the most with this procedure
is that you can really achieve a very nice mesorectal dissection
pretty much in every cadaver,
And we've done over 15 human cadavers.
We haven't published our work yet, but that will be published shortly.
But we were able to very reproducibly resect the rectum with intact mesorectum.
So as I said, we have performed this in over 15 cadavers by now.
This is the range of colon that we could mobilize anywhere between 23 and 75 centimeters.
We did have two bowel perforations during some of the endoscopic mobilization.
and we find that the factors that are associated with a difficult dissection is definitely obesity,
especially as we enter the abdomen, it becomes much harder in an obese cadaver to retract the
bowel sufficiently. And we find that obviously adhesions also is an issue and the instrumentation
is limited because it's not long and not flexible enough. Now, so what about a clinical application
of this procedure, especially for rectal resection? The question is, should we continue our work
using transgastric, hybrid transgastric and transrectal approach? Or should we focus more
on a pure transanal endoscopic approach? And I think that's unfortunately until our gastronomy
closure becomes better and until we have a substantial improvement in our instrumentation.
I think for now, these two approaches are relatively unsafe. I think to start, we should
definitely consider using a laparoscopic hybrid approach, combining laparoscopy, transabdominal
laparoscopy as well as transanal endoscopic approach to perform these procedures. And that's
precisely what we did just over a year ago. We were very fortunate to be able to collaborate
with Dr. Lacey at the Hospital Clinic of Barcelona and had a patient, and this was a IRB-approved
experimental procedure in a 76-year-old female who had a T2N1 preoperatively staged anterior
rectal cancer six centimeters from the anal verge. She was an ideal surgical candidate in that she
She was very small.
Her BMI was only 20.
She had no previous major pelvic surgery before, and she underwent standard preoperative chemoradiation
for her rectal cancer.
Now, the goal was to first access her abdomen for laparoscopy for visualization and assistance,
and we did this using a total of three ports.
We had two needle-scopic ports, as well as a 5-millimeter port through the planned stoma
site in the right lower quadrant.
The exciting part about this procedure is that we were able to perform the entire rectal
dissection, including the total mesorectal excision, endoscopically through the TEM
platform, and we used the laparoscopic approach to retract the sigmoid and help with the sigmoid
mobilization.
And we then extracted the specimen trans-anally, performed a standard hand-sewn coloanal J-pouch
anastomosis, and then we diverted the patient with a standard loop oleostomy, which would
have been done regardless.
godless. So I will show you a very quick version of that procedure. Here you will see first how we
obtain laparoscopic access to the abdomen. So anyways, essentially the steps were identical
to the cadaver model. The only difference is obviously that we were able to, we used a
laparoscopic approach to identify the left uter and really help retract the sigmoid colon while
while we did our mesenteric transection of the IMA pedicle.
The patient did very well and actually had her ileostomy closed.
Her final pathology demonstrated a T1N0 tumor with 23 negative nodes.
So, so far, there's been two published reports of this human experience
using a combined trans-anal and laparoscopic approach.
Besides our group, we also have, there's also a recent publication.
So, I think this is definitely a technique that is easily reproducible.
I don't think it's very complicated to perform, especially with TEM experience.
And I think this is something that we'll see a lot more of in the future.
Now here at MGH, we are very excited to start a study that's been already IRB approved,
so we are recruiting patients.
And the indications for this procedure will be high-risk T1 cancers, T2 and T3, no negative
rectal cancers by pelvic MRI, which are located 4 to 12 centimeters from the anal verge.
Our primary endpoint will be the adequacy of our mesorectal excision, and we also will
be looking for our secondary endpoints at perioperative outcomes.
So we're very excited to start to look at this in an IRB-supervised fashion and hope
that soon we'll be able to participate with other centers to do this on a bigger scale.
So, thank you very much for your attention and I apologize again for not being able to
show the human video.
Thank you very much, Patricia.
It's a very nice experience that you have done and I'm pretty sure that this approach
is more familiar for surgeons, so we'll get more, let's say, success among the surgical
community.
I don't know if, I know, you know Marko Liric, he's one of the first sergeants to describe
the use of the ultrasonic shears
by the TEM approach. He worked with
the Buess at the beginning of his
experience, so for sure he has a question for you.
Hi, Dr. Silla.
This is Marco Lirici. I did enjoy your
presentation. I did it
even, too, as mentioned
by Antonello. I was
used to work with Geha Buess for a long
time in the early 90s.
So
it's a great approach,
but let me ask a question what about the tissue traction because I think the very big issue in
this kind of procedure should be how to retract the viscous in the abdominal cavity so do you
think that it will be only perform as an hybrid procedure or there will be some some chances in
in the future with the new technology to have a pure
transcendental approach to major colorectal resections?
I can tell you that right now it's absolutely unsafe
to do this purely transcendentally because
of the issue, the very issue of retraction
once you get into the abdomen.
It's just impossible.
With the equipment that we have right now,
it's not long enough.
It's not flexible enough.
So right now, as it stands, it's not safe.
I mean, we're still doing a lot of work in the lab trying different other prototypes,
different other instrumentation to do this, but it's still the biggest problem right now
is that it's just not safe in every cadaver.
So some cadavers that are very thin with a very, you know, redundant colon, it's feasible
to go all the way to the splenic flexure using the flexible instrumentation that we have
right now, but in bigger pelvises with more adhesions, it's just impossible.
So, I'm hoping and I'm hopeful that industry will really come forward and help design more equipment that is more adapted for these procedures.
And I hope that as a group, we can really inspire them to design instrumentation that could be used for a pure transcendental approach.
But the big question is going to be, what type of instrumentation do we need to get those procedures done purely transcendently?
And we need help from industry to help us with that.
I have a question for you, Patricia, related to the use of the TEM platform for indication that before you considered the limit or borderline, especially related to the hate of the tumor, maybe at the retosigmoid junction.
you know because of this experience I expect that in the next future surgeons
will be more keen to operate the lesions that before there would be more suitable
for laparoscopic approach or because you didn't feel so confident to open the the
full thickness excision so which is your impression do you think that this would
be a trend for the future I think so I think the big problem that we have right
right now is, I mean, this procedure is ideal for rectal lesions all the way to the recto-sigmoid.
But the big thing, and that's what Professor Leroy is working on now, is you can't justify
this procedure that I'm describing for sigmoid lesions, because we're starting the dissection,
you know, at four centimeters. So you are going to remove the entire rectum. So you can't really
justify removing the rectum for a sigmoid, you know, cancer or a sigmoid lesion. So, you know,
the procedure is easy to perform because you're starting so low right above the sphincter complex.
But right now, it's much more difficult to start your dissection higher up. And we don't have the
really the tools yet. And I mean, you saw from Dr. Leroy's videos, you know, he's describing
starting the dissection for segmental colonic resections. But the technique is very complicated
and very difficult with many, many steps that are difficult to reproduce. So until again,
until the technology gets better, I think what I'm describing here with the TM platform is really
best suited for rectal pathology. I don't think we're ready to use this
or justify this using, you know, for more proximal lesions.
AI 对话
登录后即可通过 AI 与此视频对话。